CPT® Code 81183

Molecular genetic testing is a critical procedure used to identify mutations in various ataxin (ATXN) genes that are linked to spinocerebellar ataxia (SCA), a progressive degenerative disorder affecting the cerebellum and spinal cord. This condition manifests through a range of symptoms that can differ based on which specific gene is mutated. Common symptoms include uncoordinated gait, muscle stiffness or spasms, tremors, and difficulties with speech and swallowing. Patients may also experience problems with hand-eye coordination, involuntary eye movements, vision issues, sleep disturbances, and challenges with learning, information processing, and memory retention. The ATXN10 gene, which is the focus of this analysis, is situated on the long (q) arm of chromosome 22 at position 13.31 (22q13.31). This gene plays a vital role in neuron survival, differentiation, and the development of neurites through the mitogen-activated protein kinase cascade. The ATXN10 gene features a DNA allele characterized by a specific repeat pattern of the amino acids ATTCT within its intronic region. Typically, the normal repeat range is between 9 to 32 repeats; however, in cases of SCA10, this number can escalate dramatically to between 800 and 4500 repeats. The CPT® Code 81183 is utilized to report the ATXN10 gene analysis aimed at evaluating and detecting these abnormal (expanded) alleles.